Rohto Pharmaceutical Co (JP:4527) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Rohto Pharmaceutical Co. reported a significant decline in profits for the first half of fiscal year 2025, with net income dropping by 22.1% compared to the previous year, despite an 8.8% rise in net sales. The company has also revised its dividend forecast, reflecting cautious optimism for the remainder of the fiscal year.
For further insights into JP:4527 stock, check out TipRanks’ Stock Analysis page.